CorporateVenturing was founded by three experienced business professionals.

Paul Kristensen is a successful venture capital investor of over 30 years standing with an outstanding track record of identifying breakthrough technologies and converting them into valuable companies. Paul's portfolio includes many ventures that he has taken to listings or trade sales in markets around the world including ERG, Arbortech, Xenotech, Kinetic and Structural Monitoring Systems. He is presently Chairman of AIM-listed DDD Group Plc, a 3D visualisation company headquartered in California and founded on technology originally developed at a West Australian university. His corporate experience comprises past or present board membership of many other early-stage, venture capital invested companies. Paul's wide-ranging exposure to new technologies from all science and engineering disciplines has afforded him outstanding technology judgment and the ability to identify and strategise exceptional business opportunities. Paul is an advisor to Imprimatur Capital (UK) and MiPod Systems. He has significant experience in structuring investment, business and technology transactions in Europe, North America and Australia. Paul chairs the Western Australian Government Innovation Centre Advisory Panel and is a member of the Pathfinder Committee managing a Proof of Concept Fund supporting the emergence of early stage ventures from the University of Western Australia.

Andrew Duff is an innovation consultant who holds directorships and advisory board memberships in an array of small technology intensive companies. He consults to large corporates, new ventures, public sector research organisations and government on innovation and new venture creation through Innovation4.com and Corporate Venturing Pty Ltd. He specialises in opportunity scoping assessments and in defining value maximising development strategies for early stage ventures. In his corporate assignments he leads Corporate Venturing’s innovation process and innovation roadmapping functions as well as designing mechanisms for applying corporate financing to new ventures. In addition to his consulting roles, he has since 2000 taught a post graduate unit at the University of Western Australia Business School in new venture creation. He has worked with cross disciplinary MBA student teams assisting the development and presentation of investment proposals for 45 high technology ventures. Fourteen of these have raised private equity financing.

Michael Chappell is a successful corporate business adviser of 20 years experience. Trained as an economist, Michael been heavily involved in innovation and new venture creation since 2001. As a mentor for entrepreneurial managers, Michael has worked with dozens of start-up companies establishing governance and management systems, financial modelling and investment memoranda. His very strong abilities in market research and start-up business model design have made a significant contribution to successful business development projects in contexts covering large corporates, research and development institutions and small innovation intensive businesses. Michael is a well known and well connected member of the venture development community in Western Australia. He was responsible for initiating and leading the nucleation of a new venture around the WAIMR drug discovery science that has become Dimerix – an investee of the institutionally invested venture capital company Stone Ridge Ventures. He has mentored six MBA student teams in the development of investment proposals for new high technology ventures and is Chairman of the Board of UWA spinout company Histology-Online Pty Ltd.